Obesity Related Metabolic Disorders and Risk of Renal Disease: Impact of Hypocaloric Diet and Avena Sativa Supplement
BACKGROUND: The recognition of the complications of obesity in various organs and systems should make clinicians and dietitians aware of the importance of early strategies to fight obesity in all age groups.
AIM: The objective of this study was to evaluate the early effect of using Avena sativa (oat) flour supplement compared to a hypocaloric diet in the management of obesity-related metabolic disorders.
MATERIAL AND METHODS: Snack was prepared from wholemeal wheat flour (100% extraction) and oat flour. Chemical analysis of the raw materials and the formulae was carried out. 106 obese women with their mean body mass index were 37.73 Â± 0.56 kg/mÂ² volunteered for 8 weeks period. They were divided into two groups; group (A), consumed hypocaloric diet supplemented by the prepared snack, while group (B) subjects followed the low caloric balanced diet. All patients were monitored clinically, anthropometrically, dietary 24 h recall and biochemically.
RESULT: Data demonstrated significantly decreased in the mean levels of the anthropometric parameters. Group (A) showed a higher decrease in the waist circumference, WHR, body fat% and SBP; while in group (B) weight, BMI, chest circumference and DBP were the most affected parameters. The reduction in the biochemical parameters was higher in the group (A). At the baseline, high values of cystatin-C were found in both groups which may indicate early renal injury. At the end of the study, a significant reduction of the cystatin concentration was observed among both groups (-24.54 & -12.23%).CONCLUSION: The healthy effect of the dietary oat supplement on the reduction of central obesity, percentage body fat and different metabolic disorders criteria was confirmed than with hypocaloric diet.
Plum Analytics Artifact Widget Block
James WP. WHO recognition of the global obesity epidemic. Int J Obes (Lond). 2008; 32(Suppl 7): S120-6. https://doi.org/10.1038/ijo.2008.247 PMid:19136980
Central Agency for Public Mobilization and Statistics. Statistical Yearbook 2014. Cairo: [Arab Republic of Egypt], 2014.
Praga M, Morales E. The fatty kidney: obesity and renal disease. Nephron. 2017; 136(4):273-6. https://doi.org/10.1159/000447674 PMid:27414023
Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010; 21:406-412. https://doi.org/10.1681/ASN.2009080820 PMid:20150538 PMCid:PMC4473254
Ortiz F, Harmoinen A, Paavonen T, Koskinen P, Gronhagen-Riska C, Honkanen E. Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy? Clin Nephrol. 2008; 70(1):18-25. https://doi.org/10.5414/CNP70018 PMid:18793544
ÅšledziÅ„ski T, Proczko-Markuszewska M, Kaska Å, Stefaniak T, ÅšwierczyÅ„ski J. Serum cystatin C in relation to fat mass loss after bariatric surgery. Polish Journal of Surgery. 2012; 84(4):202-7. https://doi.org/10.2478/v10035-012-0033-0 PMid:22698658
Connolly ML, Tuohy KM, Lovegrove JA. Wholegrain oat-based cereals haveprebiotic potential and low glycaemic index. Br J Nutr. 2012; 108:2198-206. https://doi.org/10.1017/S0007114512000281 PMid:22360862
AOAC. Official Methods of Analysis of the Association of Official Analytical Chemists, 17th ed, Association of Official Analytical Chemists, Arlington, Vitginia, USA, 2000.
El-Shebini SM, Moaty MIA, Fouad S, and Tapozad ST. Serum Retinol Binding Protein-4 to Probe Insulin Resistance and Atherogenic Dyslipidemia in Metabolic Syndrome Patients Following a Diet Therapy. Research Journal of Pharmaceutical, Biological and Chemical Sciences. RJPBCS. 2016; 7(1):1903-1909.
Jelliffe DB, The assessment of the nutritional status of the community. World Health Organization, Geneva Monograph. 1966; 35: 63-69.
Barham D, Trinder P. An improved colour reagent for determination of blood glucose by oxidase system. Analyst. 1972; 97:142-145. https://doi.org/10.1039/an9729700142 PMid:5037807
Allain CC, Poon LS, Chan CS, Richmond WF, Fu PC. Enzymatic determination of total serum cholesterol. Clinical chemistry. 1974; 20(4):470-5. PMid:4818200
Wornick DF, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res.1978; 19:65-76.
Seidel J, Klos S, Ziegenhorn T. AACC Meeting Abstract 34. Clin Chem. 1993; 39:1127.
Friedewald WI, Levy RI and Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972; 18:499-502. PMid:4337382
Bonser AM, Garcia-Webb P, Harrison LC. C-peptide measurement: methods and clinical utility. CRC Critical Reviews in Clinical Laboratory Sciences. 1984; 19(4):297-352. https://doi.org/10.3109/10408368409165766 PMid:6373142
Li X, Zhou ZG, Qi HY, Chen XY, Huang G. Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2004; 29(4):419-23.
Huang XJ, Choi YK, Im HS, Yarimaga O, Yoon E, Kim HS. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors. 2006; 6(7):756-82. https://doi.org/10.3390/s6070756
Hossain M A, Emara M, El moselhi H, Shoker A: Comparing measures of Cystatin C in human sera by three methods. Am J Nephrology. 2009; 29(5):381â€“391. https://doi.org/10.1159/000168486 PMid:18974639
Rosselli MS, Lotersztain F, Vizzuttif U, Arena M, and Marra F. The metabolic syndrome and chronic liver disease. Curr Pharm Des. 2013.
Tosh SM, Shea Miller S. Health Effects of Î²-Glucans Found in Cereals. 2016, Encyclopedia of Food Grains (Second Edition), 2016; 2:236â€“240.
El Khoury D, Cuda C, Luhovyy BL, and Anderson G H. Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome. J Nutr Metab. 2012; 851362. https://doi.org/10.1155/2012/851362
WÃ¼rsch P, Pi-Sunyer FX. The role of viscous soluble fiber in the metabolic control of diabetes: a review with special emphasis on cereals rich in Î²-glucan. Diabetes Care. 1997; 20(11):1774-80. https://doi.org/10.2337/diacare.20.11.1774 PMid:9353622
Hager AS, Ryan LA, Schwab C, GÃ¤nzle MG, O'Doherty JV, Arendt EK. Influence of the soluble fibres inulin and oat Î²-glucan on quality of dough and bread. European Food Research and Technology. 2011; 232(3):405-13. https://doi.org/10.1007/s00217-010-1409-1
Sadiq-Butt M, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals. Eur J Nutr. 2008; 47:68-79. https://doi.org/10.1007/s00394-008-0698-7 PMid:18301937
Fouad S, El Shebini S M, Moaty M I, Hassan N H and Tapozada S T. Effect of Soya Beans Bread Fortified with Turmeric or Ginger on Diabesity. Der Pharma Chemica. 2016; 8(18):398-405.
Friedman AN, Wahed AS, Wang J, et al. Effect of bariatric surgery on CKD risk. J Am Soc Nephrol. 2018. https://doi.org/10.1681/ASN.2017060707 PMid:29335242
Chen HM, Shen WW, Ge YC, Zhang YD, Xie HL, Liu ZH. The relationship between obesity and diabetic nephropathy in China. BMC nephrology. 2013; 14(1):69. https://doi.org/10.1186/1471-2369-14-69 PMid:23521842 PMCid:PMC3614546
Abitbol C & RodrÃguez M. Obesity-related nephropathy in children. Pediatric Health. 2009; 3(2):141-153. https://doi.org/10.2217/phe.09.11
V Mathew A, Okada S, Sharma K. Obesity related kidney disease. Current diabetes reviews. 2011; 7(1):41-9. https://doi.org/10.2174/157339911794273928
Shardlow A, McIntyre NJ, Fraser SD, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study. PLoS medicine. 2017; 14(10):e1002400. https://doi.org/10.1371/journal.pmed.1002400 PMid:29016597 PMCid:PMC5634538
Ferguson TW, Komenda P, Tangri N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015; 24(3):295â€“300. https://doi.org/10.1097/MNH.0000000000000115 PMid:26066476
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367(1):20â€“9. https://doi.org/10.1056/NEJMoa1114248 PMid:22762315 PMCid:PMC4398023
Iglesias P, DÃez JJ. Adipose tissue in renal disease: clinical significance and prognostic implications. Nephrology Dialysis Transplantation. 2010; 25(7):2066-77. https://doi.org/10.1093/ndt/gfq246 PMid:20466661
Rouhani MH, Najafabadi MM, Surkan PJ, Esmaillzadeh A, Feizi A, Azadbakht L. The impact of oat (Avena sativa) consumption on biomarkers of renal function in patients with chronic kidney disease: A parallel randomized clinical trial. Clin Nutr. 2016; (16)31339-5.
Mellinger JL, Pencina KM, Massaro JM, Hoffmann U, Seshadri S, Fox CS, O'Donnell CJ, Speliotes EK. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. Journal of hepatology. 2015 Aug 1; 63(2):470-6. https://doi.org/10.1016/j.jhep.2015.02.045 PMid:25776891 PMCid:PMC5282653
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012 Jun 1; 142(7):1592-609. https://doi.org/10.1053/j.gastro.2012.04.001 PMid:22656328
All rights reserved.